How MoleScan Works

Traditional tele-dermatology services typically involve sending images directly to a dermatologist for review. MoleScan is a structured, doctor-led skin lesion assessment platform designed for use in real clinical workflows. Every case is reviewed by a UK GMC-registered GP with specialist expertise in dermatology (GPwSI), providing consistent, structured assessment and clear clinical outcomes. This approach enables faster, more standardised decision-making — while maintaining the clinical rigour of experienced human review.

Each case follows a structured pathway:

• Dermoscopic images and clinical information are captured by the practitioner
• The case is securely uploaded to the MoleScan platform
• A UK GPwSI reviews the images and clinical context
• A structured report is generated with a clear outcome: reassure, monitor, or refer

The process is designed to support safe, consistent decision-making — not replace clinical judgement.

MoleScan is not a diagnostic tool. It is a clinical assessment and triage platform that supports practitioners in determining whether a skin lesion requires reassurance, monitoring, or urgent referral. All cases are reviewed by a UK GP with specialist expertise in dermatology (GPwSI). Definitive diagnosis of melanoma requires histopathological confirmation following biopsy where clinically indicated.

MoleScan requires high-quality dermoscopic images for all submissions. A compatible dermatoscope attachment is required for image capture. The platform provides guidance to support practitioners in capturing clinically usable images.

Yes. Practitioners must obtain appropriate patient consent before capturing and uploading images to MoleScan. The platform supports documentation and audit trails to help clinics maintain compliant consent processes in line with UK data protection requirements.